Light Therapy for Parkinson's Disease Symptoms

This study is looking at whether a special type of light therapy, called Red Light (PDT), can help people with Parkinson's disease. Red Light (PDT) is a non-invasive (doesn't break the skin) treatment that uses low-level red light on the front of the head. Researchers believe it might increase blood flow and improve how certain brain areas work, potentially helping with Parkinson's symptoms. You would be eligible if you are between 50 and 80 years old and have a Parkinson's disease diagnosis. The study aims to see if this light therapy improves cognitive (thinking) and motor (movement) symptoms. The study's current status is unclear.

Study design
This interventional study plans to enroll 20 participants. It compares Red Light (PDT) to a placebo (a sham treatment) to see if the light therapy has an effect.
What's involved
Participants will use a helmet that delivers light therapy three times a week for six weeks. You will have cognitive and motor tests before and after this 6-week period.
Compensation
Not stated in the trial record.
Follow-up
The primary outcomes (cognitive and motor symptom improvement) are measured immediately before and after the 6-week intervention period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06916260

Light Therapy Intervention in Individuals With Parkinson's Disease

Recruiting
NAAges 50–80InterventionalTreatment
University of Delaware
~20 participants
Updated 2025-04-08 on ClinicalTrials.gov
What's tested:Red Light (PDT)Placebo

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
cognitive symptom improvement
Measured over Done immediately before (pre test) and after (post test) intervention lasting about 1 hour. The intervention lasts about 6 weeks, so in between the pre and post tests there will be about a 6 week period.
+1 more outcome measured
Parkinson Disease

NCT06916260

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • University of Delaware STAR Tower

    Newark, Delawarestudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Diagnosis of Parkinson disease
  • cognitive symptom improvementDone immediately before (pre test) and after (post test) intervention lasting about 1 hour. The intervention lasts about 6 weeks, so in between the pre and post tests there will be about a 6 week period.

    The investigators want to asses whether light therapy has a positive effect on reducing the cognitive symptoms related with PD, such as loss of short term memory, attention and processing speed. This will be measured using a set of tests and questioners (i.e MoCa, NIH cognitive battery, brief Test of attention (BTA)). Performance on these tests and questioners, which measure diverse aspects of cognition, will be compared before and after the intervention to establish if there is a positive effect of the therapy on any aspect of cognition. The intervention will last a total of 6 weeks right after the completion of the pre intervention assessment. after the completion of the 6 weeks of intervention therapy, the pre test will be conducted and cognitive measure changes will be recorded.

  • motor symptomsDone immediately before (pre test) and after(post test) intervention lasting about 1 hour. The intervention lasts 6 weeks, so there is about a 6 week period in between the two sessions ( pre and post)

    The investigators want to asses whether light therapy has a positive effect on reducing the motor symptoms related with PD, such as changes in gait, tremors, and slowing of movement. This will be measured using a set of tests and questioners (i.e MDSUPDRS, Dual task walking, APDM motion capture over a set of tests). Performance on these tests and questioners, which measure diverse aspects of motor capabilities, will be compared before (pre test) and after (post tests) the intervention to establish if there is a positive effect of the therapy on any aspect of motor control and movement. The intervention will last a total of 6 weeks, done right after the completion of the pre intervention assessment. after the completion of the 6 weeks of intervention therapy, the pre test will be conducted and any changes in motor measures will be recorded.